Skip to main content

Amentum Holdings, Inc.

For the period ended Oct 3, 2025. Filed Nov 25, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Nov 25, 2025

AMTM$22.34+5.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Balance Sheets

(in millions, except per share data)

October 3, 2025September 27, 2024
ASSETS
Current assets:
Cash and cash equivalents$437$452
Accounts receivable, net2,4792,401
Prepaid expenses and other current assets197231
Total current assets3,1133,084
Property and equipment, net114144
Equity method investments196123
Goodwill5,7035,556
Intangible assets, net1,9552,623
Other long-term assets379444
Total assets$11,460$11,974
LIABILITIES
Current liabilities:
Current portion of long-term debt$42$36
Accounts payable892764
Accrued compensation and benefits705696
Contract liabilities227113
Other current liabilities488356
Total current liabilities2,3541,965
Long-term debt, net of current portion3,9014,643
Deferred tax liabilities260370
Other long-term liabilities325444
Total liabilities6,8407,422
Commitments and contingencies (Note 21)
SHAREHOLDERS' EQUITY
Common stock, $0.01 par value – 1,000,000,000 shares authorized and 243,464,776 shares issued and outstanding at October 3, 2025; 1,000,000,000 shares authorized and 243,302,173 shares issued and outstanding at September 27, 2024.22
Additional paid-in capital4,9244,962
Retained deficit(461)(527)
Accumulated other comprehensive income4023
Total Amentum shareholders' equity4,5054,460
Non-controlling interests11592
Total shareholders' equity4,6204,552
Total liabilities and shareholders' equity$11,460$11,974
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.